Albireo Pharma Inc
F:BDQM
Fundamental Analysis

Revenue & Expenses Breakdown
Albireo Pharma Inc
Balance Sheet Decomposition
Albireo Pharma Inc
Current Assets | 238.8m |
Cash & Short-Term Investments | 222.5m |
Receivables | 2m |
Other Current Assets | 14.3m |
Non-Current Assets | 82.4m |
PP&E | 1.3m |
Intangibles | 17.3m |
Other Non-Current Assets | 63.8m |
Free Cash Flow Analysis
Albireo Pharma Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Albireo Pharma Inc
Revenue
|
57.4m
USD
|
Cost of Revenue
|
-2.5m
USD
|
Gross Profit
|
54.8m
USD
|
Operating Expenses
|
-177.8m
USD
|
Operating Income
|
-122.9m
USD
|
Other Expenses
|
-8.2m
USD
|
Net Income
|
-131.1m
USD
|
BDQM Profitability Score
Profitability Due Diligence
Albireo Pharma Inc's profitability score is 23/100. The higher the profitability score, the more profitable the company is.
Score
Albireo Pharma Inc's profitability score is 23/100. The higher the profitability score, the more profitable the company is.
BDQM Solvency Score
Solvency Due Diligence
Albireo Pharma Inc's solvency score is 55/100. The higher the solvency score, the more solvent the company is.
Score
Albireo Pharma Inc's solvency score is 55/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
BDQM Price Targets Summary
Albireo Pharma Inc
Dividends
Current shareholder yield for BDQM is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?